Skip to main content
Premium Trial:

Request an Annual Quote

Evotec Licenses Cellomics HCS Patent Portfolio

NEW YORK, Jan. 30 (GenomeWeb News) - Evotec has signed a non-exclusive patent license agreement for Cellomics HCS portfolio, Cellomics announced today.


The two companies are also collaborating to integrate software and assay products, including validation of Cellomics' assay kits by Evotec, said Cellomics.


Financial details were not disclosed.


Cellomics, a unit of Fisher Biosciences, provides a cell-based platform.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.